SCHEMBL23296325

SCHEMBL23296325

Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccccc2-c2cccc(C#N)c2-c2ccccc2-c2ccc(-n3c4ccccc4c4cc(C)ccc43)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.36
IMPDH2 P12268 1/20 0.34
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
GAA P10253 2/20 0.34
HSD17B10 Q99714 2/20 0.34
PDE9A O76083 1/20 0.34
PDE1C Q14123 1/20 0.34
GLA P06280 1/20 0.34
CASP1 P29466 1/20 0.34
RECQL P46063 1/20 0.34
CASP7 P55210 1/20 0.34
NR3C1 P04150 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31272663 0.94 PDE9A (0.39) PTGDR2KDM4EALDH1A1HPGDGAA
SCHEMBL31663565 0.90 ALDH1A1 (0.41) PTGDR2KDM4EALDH1A1HPGDGAA
SCHEMBL31273030 0.89 PDE9A (0.39) PTGDR2KDM4EALDH1A1HPGDGAA
SCHEMBL31663632 0.89 PDE9A (0.40) PTGDR2KDM4EALDH1A1HPGDGAA
SCHEMBL31663554 0.89 PDE9A (0.40) PTGDR2KDM4EALDH1A1HPGDGAA
SCHEMBL24547907 0.89 PDE9A (0.40) PTGDR2IMPDH2KDM4EALDH1A1HPGD
SCHEMBL17949571 0.87 ESR2 (0.40) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL31663611 0.86 ALDH1A1 (0.41) PTGDR2KDM4EALDH1A1HPGDGAA
SCHEMBL24548199 0.84 KDM4E (0.38) IMPDH2KDM4EALDH1A1HPGDGAA
SCHEMBL31663564 0.83 PDE9A (0.38) PTGDR2KDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 PTGDR2 3664/4885IMPDH2 2137/4885KDM4E 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.